Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age;Akut lymfoblastær leukæmi hos børn og unge på 10-19 år i Danmark

Ugeskrift for Laeger

Volumn 168, Issue 26-32, 2006, Pages 2554-2558

  Schrøder, Henrik ^a   Kjeldstad, Marthe ^b   Boesen, Anne Marie ^b   Nielsen, Ove Juul ^b   Schmidt, Kai Gjerløff ^b   Johnsen, Hans Erik ^b   Gregersen, Henrik ^b   Gustafsson, Göran ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; CANCER REGISTRY; CANCER SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DENMARK; DRUG MEGADOSE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MEDICAL SOCIETY; OVERALL SURVIVAL; REVIEW; SCHOOL CHILD; SURVIVAL RATE; ACUTE LYMPHOCYTIC LEUKEMIA; ADJUVANT THERAPY; ARTICLE; CHILD; COMPARATIVE STUDY; FEMALE; MALE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PREDNISONE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VINCRISTINE;

EID: 33746549329     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Gustafsson G. Annual report from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Stockholm: Barncancerforskningsenheten, 2002.
2. Chessells JM, Hall E, Prentice HG et al. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 1998;12:463-73.
3. Stiller CA, Benjamin S, Cartwright RA et al. Patterns of care and survival for adolescents and young adults with acute leukaemia. Br J Cancer 1999;79: 658-65.
4. Jeha S. Who should be treating adolescents and young adults with acute lymphoblastic leukaemia? Eur J Cancer 2003;39:2579-83.
5. Boissel N, Auclerc MF, Lheritier et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-80.
6. De Bont JM, Holt B, Dekker AW et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004;18:2032-5.
7. Nachman J, Sather HN, Buckley JD et al. Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Cancer 1993;71(10 suppl): 3377-85.
8. Stock W, Sather HN, Dodge RK et al J. Outcome of adolescents and young adults with ALL: A comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens. Blood 2000;96:467.
9. Gustafsson G, Kreuger A, Clausen N et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatr 1998;87:1151-61.
10. Larson RA, Dodge RK, Burns CP et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995;85:2025-37.
11. Schrappe M, Reiter A, Ludwig WD et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000;95:3310-22.
12. Bleyer WA, Tejeda H, Murphy SB et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 1997;21: 366-73.
13. Hollis R, Morgan S. The adolescent with cancer - at the edge of no-man's land. Lancet Oncol 2001;2:43-8.
14. Nachman JB. Adolescents with acute lymphoblastic leukemia: a new "age". Rev Clin Exp Hematol 2003;7:261-9.
15. Daenen S, van Imhoff GW, van den BE et al. Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a "pre-induction" course for rapid tumour reduction: preliminary results on 66 patients. Br J Haematol 1998;100:273-82.
16. Kantarjian HM. Adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001;15:207-11, viii.
17. Linker C, Damon L, Ries C et al. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 2002;20:2464-71.
18. Linker CA. Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL). Leukemia 1997;11(suppl 4):S24-S27.